ArticleSignal transduction and targeted therapy2026
Correction: RBM4 dictates ESCC cell fate switch from cellular senescence to glutamine-addiction survival through inhibiting LKB1-AMPK-axis.
Lei Chen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.